Keyphrases
Epidemiology
100%
Virus
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Human Cancer
100%
Hepatitis C Virus
100%
Hepatitis B Virus
100%
Virus Hepatitis
100%
Virus Infection
100%
Epstein-Barr Virus
75%
Carcinogen
75%
Hepatocellular Carcinoma
50%
Nasopharyngeal Carcinoma
50%
Risk Prediction
50%
Oncogenic Viruses
50%
Human Immunodeficiency Virus Type 1 (HIV-1)
50%
Virus Type
50%
Kaposi's Sarcoma-associated Herpesvirus
50%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
50%
Risk Calculator
50%
Chronic Inflammation
25%
Clinical Trials
25%
Epidemiological Study
25%
National Program
25%
Human Carcinogen
25%
Mechanistic Studies
25%
Immunization
25%
Antiretroviral Therapy
25%
Viral
25%
Cervical Cancer
25%
Infected Patients
25%
Persistent Infection
25%
Viral Genotype
25%
Gene-gene Interaction
25%
Serial Measurements
25%
Viral Host
25%
Cancer Incidence
25%
B Hepatitis
25%
Cervical Carcinoma
25%
Clinical Management
25%
Biosignatures
25%
Human Host
25%
Long-run Risk
25%
Gene-environment Interaction
25%
High Viral Load
25%
International Agency for Research on Cancer
25%
Immune Suppression
25%
Medicine and Dentistry
Cohort Effect
100%
Malignant Neoplasm
100%
Virus Infection
100%
Virus
100%
Wart Virus
66%
Cancer
66%
Hepatitis B Virus
66%
Hepatitis Virus
66%
Hepatitis C Virus
66%
Carcinogen
66%
Hepatocellular Carcinoma
33%
Nasopharynx Carcinoma
33%
Virus Typing
33%
T Cell
33%
Human Immunodeficiency Virus 1
33%
Kaposi Sarcoma
33%
Tumor Virus
33%
Herpesviridae
33%
Chronic Inflammation
16%
Clinical Trial
16%
Immunosuppressive Treatment
16%
Cervical Cancer
16%
Triage
16%
Clinical Management
16%
Antiviral Therapy
16%
Uterine Cervix Carcinoma
16%
Persistent Infection
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Human Papillomavirus
100%
Carcinogen
100%
Hepatitis B Virus
100%
Hepatitis C Virus
100%
Virus Infection
100%
Virus Hepatitis
100%
Liver Cell Carcinoma
50%
Nasopharynx Carcinoma
50%
Human Immunodeficiency Virus 1
50%
Herpesviridae
50%
Tumor Virus
50%
Kaposi Sarcoma
50%
Chronic Inflammation
25%
Clinical Trial
25%
Antiviral Therapy
25%
Uterine Cervix Cancer
25%
Uterine Cervix Carcinoma
25%
Persistent Infection
25%